1/30/2015 - 10:55 AM EST - Valeant Pharmaceuticals International, Inc. : announced that bankrupt drug maker Dendreon has reached a stalking-horse deal with Valeant to sell rights to its prostate cancer vaccine, Provenge, and certain assets for $296 million U.S.The deal is subject to higher and better offers until Feb. 10. Valeant Pharmaceuticals International, Inc.
shares T.VRX are trading down $0.67 at $202.96.
